Lennox International (NYSE:LII) will be added to the S&P 500 Index (SP500), replacing Catalent (CTLT) as the contract drug ...
Hosted on MSN13h
Lennox (LII) Upgraded to Buy: Here's WhyLennox International (LII) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
Lennox International, an AI cooling play, will join the S&P 500 before the open on Dec. 23. Bill Holdings will take its place ...
1d
Wilmington Savings Fund Society FSB acquired a new position in shares of Lennox International Inc. (NYSE:LII – Free Report) ...
Heating and air conditioning equipment maker Lennox International Inc. is replacing contract drug maker Catalent Inc. in the ...
Lennox International Inc (LII) stock saw a modest uptick, ending the day at $628.28 which represents a slight increase of $8.40 or 1.36% from the prior close of $619.88. The stock opened at $619.97 ...
In recent trading, shares of Lennox International Inc (Symbol: LII) have crossed above the average analyst 12-month target price of $620.21, changing hands for $628.28/share. When a stock reaches ...
Lennox (LII) announced its inclusion in the S&P 500 Index, effective prior to the opening of trading. This milestone recognizes the ...
Long term Lennox International Inc. (NYSE:LII) shareholders would be well aware of this, since the stock is up 170% in five years. Meanwhile the share price is 1.7% higher than it was a week ago.
S&P MidCap 400 constituent Lennox International Inc. (NYSE: LII) will replace Catalent Inc. (NYSE: CTLT) in the S&P 500, and BILL Holdings Inc. (NYSE: BILL) will replace Lennox International in the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback